🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of AR-42 when giv...
Status
Completed
Location
Cincinnati Children's Hospital
Start Date
2013-09-17
Trial ID
NCT01798901
Treatments Being Tested
The goal of this phase 2 clinical trial is to test the efficacy of decitabi...
Status
Recruiting
Location
Seoul National University Bundang Hospital
Start Date
2025-01-30
Trial ID
NCT06712121
Treatments Being Tested
This is a single institution study of combining decitabine with fludarabine...
Status
Completed
Location
Hackensack University Medical Center - John Theurer Cancer Center
Start Date
2009-05
Trial ID
NCT01455506
Treatments Being Tested
The purpose of this study is to find out if oral decitabine-cedazuridine (I...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-04-01
Trial ID
NCT06351306
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of FT-2102 wh...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-08-27
Trial ID
NCT04013880
Treatments Being Tested
The goal of this clinical research study is to compare how 2 different drug...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2014-10-13
Trial ID
NCT02269280
This phase I trial is studying the side effects and best dose of decitabine...
Status
Terminated
Location
Princess Margaret Hospital Phase 2 Consortium
Start Date
2002-09
Trial ID
NCT00049582
Treatments Being Tested
This phase II trial tests how well decitabine and cedazuridine (DEC-C) work...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-04-13
Trial ID
NCT05799079
Treatments Being Tested
Background: Acute myeloid leukemia (AML) is a cancer of the white blood ce...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2016-12-16
Trial ID
NCT02996474
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of nivolum...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2022-11-03
Trial ID
NCT05272384